Hexadecyl phosphate is an organophosphate compound with the formula CH3(CH2)15OPO3H2. It is a white, waxy solid that is soluble in organic solvents. Hexadecyl phosphate is used as a surfactant, emulsifier, and lubricant. It is also used in the synthesis of other organophosphate compounds. The compound is synthesized by reacting hexadecanol with phosphorus pentoxide. The compound is studied for its potential use in a variety of applications, including cosmetics, pharmaceuticals, and agricultural chemicals. Hexadecyl phosphate is a relatively safe compound, but it can cause skin and eye irritation. It is important to handle hexadecyl phosphate with care and to wear appropriate safety equipment.'
| ID Source | ID |
|---|---|
| PubMed CID | 19059 |
| CHEMBL ID | 479322 |
| SCHEMBL ID | 63748 |
| MeSH ID | M0057799 |
| Synonym |
|---|
| 3539-43-3 |
| 1-hexadecanol, dihydrogen phosphate |
| hexadecyl dihydrogen phosphate |
| hexadecyl phosphate |
| cetyl phosphate |
| CHEMBL479322 |
| 1-hexadecanol, 1-(dihydrogen phosphate) |
| vt07d6x67o , |
| unii-vt07d6x67o |
| einecs 222-581-1 |
| FT-0634894 |
| cetyl dihydrogen phosphate |
| mackester cep |
| phosphoric acid monohexadecyl ester |
| cetyl phosphate [inci] |
| crodafos mca |
| hostaphat cc 100 |
| 1-hexadecanol,1-(dihydrogen phosphate) |
| SCHEMBL63748 |
| DTXSID1045039 |
| ZUVCYFMOHFTGDM-UHFFFAOYSA-N |
| monocetylphosphoric acid |
| phosphoricmonohexadecyl ester |
| monocetyl phosphate |
| AMY13853 |
| amphisol a |
| Q27292009 |
| amphisola |
| Product Category | Products |
|---|---|
| Beauty & Personal Care | 1 |
| Product | Brand | Category | Compounds Matched from Ingredients | Date Retrieved |
|---|---|---|---|---|
| cocokind Spot Treatment Turmeric Tonic -- 0.5 fl oz | cocokind | Beauty & Personal Care | glyceryl stearate, glycerin, cetyl phosphate, stearyl alcohol | 2024-11-29 10:47:42 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID376840 | Antifungal activity against Candida albicans B311 by standard microdilution method | 1999 | Journal of natural products, Jun, Volume: 62, Issue:6 | Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata. |
| AID376841 | Antifungal activity against Candida albicans 572-27 by standard microdilution method | 1999 | Journal of natural products, Jun, Volume: 62, Issue:6 | Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata. |
| AID376842 | Antifungal activity against Cryptococcus neoformans 96-69 by standard microdilution method | 1999 | Journal of natural products, Jun, Volume: 62, Issue:6 | Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata. |
| AID376837 | Antifungal activity against Candida albicans ATCC 10259 by standard microdilution method | 1999 | Journal of natural products, Jun, Volume: 62, Issue:6 | Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata. |
| AID376838 | Antifungal activity against Cryptococcus neoformans ATCC 36556 by standard microdilution method | 1999 | Journal of natural products, Jun, Volume: 62, Issue:6 | Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata. |
| AID376839 | Antifungal activity against Aspergillus fumigatus ATCC 13073 by standard microdilution method | 1999 | Journal of natural products, Jun, Volume: 62, Issue:6 | Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.85) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||